brilinta

Generic: ticagrelor

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name brilinta
Generic Name ticagrelor
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 90 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-815
Product ID 71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022433
Listing Expiration 2026-12-31
Marketing Start 2011-08-05

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610815
Hyphenated Format 71610-815

Supplemental Identifiers

RxCUI
1116635 1116639
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brilinta (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number NDA022433 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 90 mg/1
source: ndc
Packaging
  • 5400 TABLET in 1 BOTTLE (71610-815-41)
source: ndc

Packages (1)

71610-815-41 5400 TABLET in 1 BOTTLE (71610-815-41)

Ingredients (1)

ticagrelor (90 mg/1)

Linked Drug Pages (1)

BRILINTA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "159d6ad1-edcf-d4da-e063-6294a90a6adb", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1116639"], "spl_set_id": ["1547e2b6-8858-178e-e063-6394a90abb23"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "5400 TABLET in 1 BOTTLE (71610-815-41)", "package_ndc": "71610-815-41", "marketing_start_date": "20240403"}], "brand_name": "BRILINTA", "product_id": "71610-815_159d6ad1-edcf-d4da-e063-6294a90a6adb", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "71610-815", "generic_name": "Ticagrelor", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRILINTA", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "NDA022433", "marketing_category": "NDA", "marketing_start_date": "20110805", "listing_expiration_date": "20261231"}